Prognostic significance of carcinoma in situ in the vicinity of non small cell resected lung cancer in stage I to IIIA

被引:1
|
作者
Aubert, A
Moro-Sibilot, D
Diab, S
Riehl, G
Lantuejoul, S
Brambilla, E
Brichon, P
Brambilla, C
机构
[1] Ctr Hosp Univ Grenoble, Dept Chirurg Thorac Vasc & Endocrinienne, F-38706 Grenoble, France
[2] INSERM, Lung Canc Res Grp, U578, Inst A Bonniot, La Tronche, France
关键词
D O I
10.1016/S0169-5002(05)80302-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S57 / S57
页数:1
相关论文
共 50 条
  • [31] Prognostic significance of polysialic acid expression in resected non-small cell lung cancer
    Tanaka, F
    Otake, Y
    Nakagawa, T
    Kawano, Y
    Miyahara, R
    Li, M
    Yanagihara, K
    Inui, K
    Oyanagi, H
    Yamada, T
    Nakayama, J
    Fujimoto, I
    Ikenaka, K
    Wada, H
    CANCER RESEARCH, 2001, 61 (04) : 1666 - 1670
  • [32] Prognostic value of preoperative plasma fibrinogen levels in resected stage I non-small cell lung cancer
    Mitsui, Suguru
    Tanaka, Yugo
    Doi, Takefumi
    Hokka, Daisuke
    Maniwa, Yoshimasa
    THORACIC CANCER, 2022, 13 (10) : 1490 - 1495
  • [33] Prognostic Factors for Post Recurrence Survival in Resected Pathological Stage I Non-small Cell Lung Cancer
    Kubouchi, Yasuaki
    Kidokoro, Yoshiteru
    Ohno, Takashi
    Yurugi, Yohei
    Wakahara, Makoto
    Haruki, Tomohiro
    Nakamura, Hiroshige
    YONAGO ACTA MEDICA, 2017, 60 (04) : 213 - 219
  • [34] Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer
    Goodgame, Boone
    Pillot, Giancarlo A.
    Yang, Zhiyun
    Shriki, Jabi
    Meyers, Bryan F.
    Zoole, Jennifer
    Gao, Feng
    Dehdashti, Farrokh
    Patterson, Alexander
    Siegel, Barry A.
    Govindan, Ramaswamy
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (02) : 130 - 134
  • [35] Prognostic Factors of Post-Recurrence Survival in Resected Stage I Non-Small Cell Lung Cancer
    Kubouchi, Yasuaki
    Kidokoro, Yoshiteru
    Oono, Takashi
    Yurugi, Yohei
    Wakahara, Makoto
    Miwa, Ken
    Araki, Kunio
    Taniguchi, Yuji
    Nakamura, Hiroshige
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S650 - S650
  • [36] Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer
    Graziano, SL
    Gamble, GP
    Newman, NB
    Abbott, LZ
    Rooney, M
    Mookherjee, S
    Lamb, ML
    Kohman, LJ
    Poiesz, BJ
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) : 668 - 675
  • [37] Randomised study of adjuvant chemotherapy for completely resected p-stage I–IIIA non-small cell lung cancer
    K Nakagawa
    H Tada
    A Akashi
    T Yasumitsu
    K Iuchi
    T Taki
    K Kodama
    British Journal of Cancer, 2006, 95 : 817 - 821
  • [38] Preparation for a new TNM stage: The prognostic significance of multiple station N2 in stage IIIA non small cell lung cancer
    Lee, Jin Gu
    Lee, Chang Young
    Park, In Kyu
    Kim, Dae Joon
    Chung, Kyung Young
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S321 - S321
  • [39] Completely resected stage IIIA non-small cell lung cancer: The significance of primary tumor location and N2 station
    Ichinose, Y
    Kato, H
    Koike, T
    Tsuchiya, R
    Fujisawa, T
    Shimizu, N
    Watanabe, Y
    Mitsudomi, T
    Yoshimura, M
    Tsuboi, M
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 122 (04): : 803 - 808
  • [40] Early stages of non small cell lung cancer (I. II. IIIA) -: Postoperative treatments for resected non small-cell lung cancer
    Barlesi, E.
    REVUE DES MALADIES RESPIRATOIRES, 2006, 23 (05) : S47 - S53